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Subcortical white matter is disrupted in cerebral vascular disease and dementia. Cerebral hypoperfusion is often linked with pathological changes in white matter (O’Sullivan, 2002) which have been detected using imaging approaches in vivo such as diffusion tensor imaging (Bucur, 2008; Bastin, 2009; Benjamin, 2015). Neuropathological investigations have also revealed marked alterations in white matter including  reductions in myelin density in vascular disease (Ihara, 2010 (​http:​/​​/​brain.oxfordjournals.org​/​content​/​139​/​1​/​242" \l "ref-26​); Barker, 2013 (​http:​/​​/​brain.oxfordjournals.org​/​content​/​139​/​1​/​242" \l "ref-6​)) with evidence that this may be related to reduced white matter perfusion (Fernando, 2006; Barker, 2014 (​http:​/​​/​brain.oxfordjournals.org​/​content​/​139​/​1​/​242" \l "ref-5​)).  Importantly the extent and presence of these white matter changes are now considered to be important determinants of cognitive function and influence dementia (Prins, 2015; Chen, 2016). 

We and others have shown using experimental models of cerebral hypoperfusion that the brain’s white matter is particularly vulnerable to modest reductions in blood flow. Specifically, reduced cerebral perfusion elicits diffuse damage to myelinated axons accompanied by a pronounced pro-inflammatory response and impaired spatial working memory.  (Shibata, 2004; Coltman, 2011; Holland, 2011; McQueen, 2014; Reimer, 2011; Holland, 2015) Moreover, hypoperfusion leads to the disruption of key paranodal and internodal proteins which are essential for the stability of the axon-glial connection (Reimer, 2011). Myelinated axons have a unique and highly organised molecular structure that enables rapid and efficient action potential propagation (Hartline and Colman, 2007). Alterations in axon-glial integrity and disruption of the protein architecture of nodal regions have been shown to impair axonal function (Boyle, 2001; Nie, 2006; Pillai, 2009; Ritter, 2013). Indeed, recent mathematical modelling indicates that subtle paranodal disruption is sufficient to  significantly slow axonal conduction velocity i.e., the speed at which action potentials propagate along myelinated axons  (Babbs and Shi, 2013). As yet mechanisms linking subtle reductions in blood flow to axon-glial alterations are unknown as are the impacts this has on axonal function.

Microglia are the resident immune cells of the brain and, in response to injury, secrete various factors such as cytokines and chemokines that can modulate the pathological outcome. Increased numbers of microglia often accompany damage to myelinated axons in rodent models of hypoperfusion (Coltman, 2011; Reimer, 2011; McQueen, 2014). Similarly increased numbers of microglia have been identified in white matter lesions in aged post-mortem human brain (Simpson, 2007). Activated microglia (defined by their altered morphology and increased expression of pro-inflammatory genes) predominate in the white matter of aged primate brain and correlate with cognitive impairment (Sloane, 1999). Increased numbers of activated microglia have also been linked to axon-glial disruption in an experimental model of multiple sclerosis (Howell, 2010). It is not clear, however, whether these changes in microglia number or phenotype contribute to, or are consequence of, the damage to myelinated axons. Potential anti-inflammatory agents or drugs that inhibit microglia, such as minocycline, can exert a protective effect on white matter structure as a consequence of hypoperfusion (Choe et al. 2006; Ma et al. 2015) and hypoperfusion/ hypertension (Jalal, 2015). However to date it is not known whether minocycline has a protective effect on white matter function and if this  is related to microglia.

The aim of the present study was to investigate whether, in response to increased durations of hypoperfusion, the functional integrity of white matter is impaired and related to axon-glial integrity and microglia numbers/proliferation. Second to this we tested the potential protective effect of minocycline on white matter function and microglia numbers/proliferation.
MATERIALS AND METHODS
Animal cohorts




Chronic cerebral hypoperfusion and minocycline treatment
Chronic cerebral hypoperfusion was induced by bilateral carotid artery stenosis as previously described (Coltman, 2011; Reimer, 2011). Briefly, 0.18 mm internal diameter microcoils (Sawane Spring Co, Shizuoka, Japan) were fitted in both common carotid arteries under isoflurane anaesthesia (induced at 5% and maintained at 1.2-1.6%). A 30 minute interval was left between the placement of the first and second coil. Sham mice underwent the exact same surgical procedure with the exception that coils were not applied to the arteries. Animals were housed with free access to food and water in a 12-h dark-light cycle under constant temperature and carefully monitored throughout the experiment.  Minocycline (Sigma) or vehicle was injected at a dose of 50mg/kg,ip every other day for 10weeks starting from day 1 after hypoperfusion surgery. This mode of drug administration was undertaken in order that we could control the dose of minocycline each mouse received.  The mice habituated readily to this mode of injection. The researchers were blind to the drug administered and surgery.  

Tissue collection
At defined survival times after surgery, mice were sacrificed  and their brains were quickly removed on top of a frozen petri-dish with a few drops of sucrose artificial cerebrospinal fluid -aCSF- (189 mM Sucrose, 10 mM D-glucose, 26 mM NaHCO3, 3mM KCl, 5mM MgCl2, 0.1 mM CaCl2, 1.25mM NaH2PO4). The brain was then rapidly dissected, placed in a cell strainer and submerged in ice-cold oxygenated (carbogen 95% O2, 5% CO2, BOC, UK) sucrose aCSF for 2-3 minutes. The brain was then glued to the cooled specimen block after carefully removing the cerebellum, transferred to the cutting chamber and submerged in oxygenated ice-cold sucrose aCSF. Sections were then cut at 400 µm using a vibrating blade microtome (Hydrax V50, Zeiss, Cambridge, UK). A single coronal slice (in the region of -1.2-1.7 mm Bregma) was then transferred to a warmed (34°C) incubation chamber (BSK1, Digitimer, Welwyn Garden City, UK) with oxygenated aCSF (124 mM NaCl, 5 mM KCL, 1.25 mM NaH2PO4, 26 mM NaHCO3, 1.3 mM MgSO4, 2 mM CaCl2, 10 mM D-Glucose) for one hour before electrophysiological recording. An adjacent 1.5 mm thick slice, to that of the recording slice, was cut and immediately post-fixed for 24h in 4% paraformaldehyde, rinsed in phosphate buffer and processed for paraffin embedding.

Electrophysiology 
Recording procedures were similar to those previously published (Crawford, 2009). Briefly, following at least a 1 hour period of post-slicing recovery slices were carefully transferred to a recording chamber (RC27L, Harvard Apparatus, Cambridge, UK) mounted on an Olympus BX51 microscope (Olympus, KeyMed House, Southend-on-Sea, UK) where they were superfused with oxygenated aCSF (2-3 ml/min) at 24°C. This temperature was employed to enable discrimination of compound actions potentials arising from myelinated and unmyelinated fibres. Slices were supported by a slice anchor and then allowed to rest for 30 minutes prior to recording. A bipolar stimulating electrode (WPI Inc, Hertfordshire, UK) with manually blunted tips was lowered into the corpus callosum ~1 mm lateral to the midline using a manual manipulator and constant current stimulus-isolated square wave pulses (NL800, Digitimer, Welwyn Garden City, UK ) were applied to evoke compound action potentials (CAP). Recording electrodes were pulled from borosilicate glass capillaries (1.5/0.84 mm OD/ID, 100 mm long, WPI Inc., Hertfordshire, UK) and back filled with aCSF to give a final resistance of 1-3MΩ. These were connected to the amplifier’s headstage via an Ag/AgCl wire and then lowered into the corpus callosum (Patchstar micromanipulator, Scientifica, East Sussex, UK) adjacent to the midline 2 mm contralateral to the stimulating electrode. For analysis of the CAP peak amplitude standardised input-output functions were generated by varying the intensity of stimulus pulse (200 μs duration, 0.2 Hz) in 0.25 mA increments from 0.25-4 mA. To enhance the signal to noise ratio, all electrophysiology analysis was conducted on averaged waveforms of four successive sweeps. Evoked CAPs were amplified (x500) and filtered (bandpass = DC to 10 kHz) using an Axopatch 200A amplifier in voltage following mode (Molecular Devices, Berkshire, UK). Responses were digitized at 200 kHz, and recorded for offline analysis using pClamp software (v10, Molecular Devices, Berkshire, UK). To assess the conduction velocity CAPs were evoked at the maximal stimulation of 4 mA and the distance between the stimulating and recording electrode altered in 0.5 mm increments from 1-2.5 mm by moving the recording electrode. The post-stimulus latency of the CAP peak was then recorded and the conduction velocity calculated based on the distance. 

Immunohistochemistry
Paraffin sections were cut at 10μm thickness. Free floating cryo-preserved sections cut at 30μm thickness were used for the Iba-1, TMEM119 co-localisation. The antibodies used in this study were the following: Nav1.6 (1:100, AB5580, Millipore, Nottingham, UK), Caspr (1:50, clone K65/35; UC Davies NIH NeuroMab, USA), Iba-1 (1:1000 for DAB, 1:100 for fluorescence, MP-290-CR05, Menarini, Wokingham, UK), (1:4000 for DAB, 1:500 for fluorescence, ab5076, Abcam, Cambridge, UK), Ki67 (1:25 for VIP labelling, ab16667, Abcam, Cambridge, UK), TMEM119 (1:500, ab209064 , Abcam, Cambridge, UK), MAG (1:500, L20, sc-9543; Santa Cruz Biotechnology, Heidelberg, Germany). Fluorescent secondary antibodies Alexa Fluor 488, 546 and 647 (1:500) and Streptavidin Alexa Fluor 546 (1:100) were purchased from Life technologies Ltd (Loughborough, UK). Non-fluorescent biotinylated secondary antibodies were purchased from Vector Laboratories (Peterborough, UK). All sections were heat-retrieved with either EDTA pH 8 or citrate pH 6 and primary antibodies were incubated overnight at 4 °C in blocking buffer (Iba-1, MAG and Caspr, MAG, Iba-1 triple label) or blocking buffer with 0.3% Triton X-100 (Nav1.6 and Caspr double label). Sections were stained at the outset with haematoxylin and eosin to determine the presence and absence of ischemic neuronal perikaryal damage as part of the inclusion/exclusion criteria.

Analysis of Immunohistochemistry
Immunolabeled 10 µm paraffin sections were analysed using either a laser scanning confocal microscope Leica SP5 C (Milton Keynes, UK; fluorescent double and triple label) or an optical microscope Olympus BX51 (Olympus, KeyMed House, Southend-on-Sea, UK; MAG and Iba-1). Immunolabeled 30 µm free floating cryo-preserved sections immunostained with Iba-1 and TMEM119 were analysed using a laser scanning confocal microscope Zeiss LSM710 (Zeiss, Cambridge, UK). 
Node-paranode measures
Images from the corpus callosum of both hemispheres (Interaural 1.98 mm; Bregma 1.82 mm according to Franklin and Paxinos, 1997) were acquired with a 63x oil-immersion objective (numerical aperture 1.4), a pinhole of 1 Airy unit and a 1024 x 1024 pixel resolution. The corresponding Nyquist settings, 4.7x zoom and 0.13 µm z-step, were used to deconvolve the image (Huygens Professional Deconvolution Software; SVI, Hilversum, The Netherlands). All length measurements were performed using ImageJ (FIJI) and the observer was blinded to the surgical procedure. 
The nodal gap length, distance between paired Caspr+ rectangular clusters, and the length of the sodium channel cluster, were measured in image stacks spanning 6 µm. The first 20 nodes that appeared in the stack and were not in contact with the borders of the image were selected for length measurements using the line tool of ImageJ. In addition, the nodal-paranodal ratio was also calculated dividing the length of the sodium channel cluster of a given node by its nodal gap length.
Iba-1, Ki67 and MAG measures
The loss of axon-glial integrity of the corpus callosum was assessed using MAG immunostaining and graded from 0 (none) to 3 (extensive). Myelin damage identified with MAG was determined as the presence of disorganised white matter fibres and myelin debris.  The scale was as follows; normal (grade 0), minimal myelin debris, vacuolation, and disorganisation of fibres (grade 1), modest myelin debris, vacuolation, and disorganisation of fibres (grade 2), and extensive myelin debris, vacuolation, and disorganisation of fibres (grade 3). Microglia were identified using Iba-1 and the number of positively stained cells in the corpus callosum was counted. In order to evaluate proliferation of microglia, Iba-1 was co-labelled with Ki67 and the percentage of Iba-1/Ki67 cells measured within the corpus collosum.
Caspr, MAG and Iba-1 triple label imaging 
Images from the corpus callosum with high and low densities of microglial cells (Interaural 1.98 mm; Bregma 1.82 mm) were acquired at different magnifications using a 40x oil-immersion objective (numerical aperture 1.25) or a 100x oil-immersion objective (numerical aperture 1.4), a pinhole of 1 Airy unit and a 1024 x 1024 pixel resolution. The corresponding Nyquist settings were used to deconvolve the images (Huygens Professional Deconvolution Software; SVI, Hilversum, The Netherlands). 
Iba-1, TMEM119 double labelling
Images from the corpus callosum (Interaural 1.98 mm; Bregma 1.82 mm) were acquired at 20x magnification (numerical aperture 0.8), pinhole of 1-2 Airy units and a 1024 x 1024 pixel resolution. Images were then examined in a blinded manner for Iba-1+ TMEM119- cells within the white matter. 

Real time quantitative real time polymerase chain reaction (RT-qPCR)











Generated cDNA was first combined with forward and reverse primers, Platinum SYBR Green qPCR Supermix-UDG and ROX reference dye in DNase/RNase-free water. The thermal profile was then performed using a Stratagene Mx3005P thermocycler (Agilent) of the following steps:  denaturation 95oC 10 min (1cycle);  amplification, 95oC 15 sec,  60oC 20 sec, 72oC 1 min (40cycles); elongation 95oC 1 min, 55oC 30 sec, 95oC 30 sec (1 cycle). Calculated cycle threshold (Ct) values were normalised to values obtained for the housekeeping gene Gapdh and the 2^∆∆CT method was used to determine expression fold change relative to sham control group.

Statistical analysis
Data are presented as mean ± SEM with the exception of nodal gap and nodal-paranodal ratio data which were plotted as cumulative and relative frequency (%), respectively. Electrophysiology data and microglia counts were analysed using ANOVA and Student’s unpaired t-test. Semi-qualitative MAG grading was analysed with Chi-square test for trend and nodal measures were analysed using a two-sample Kolmogorov-Smirnov test. The percentage of Iba1/Ki67 colocalised cells was compared across groups using Kruskal Wallis. Correlation analyses were done using either Pearson or Spearman test depending on parametric or non-parametric distribution of the data. Unless otherwise indicated, a probability (p) value of < 0.05 was considered to be statistically significant. 

RESULTS
Functional integrity of white matter is progressively impaired in response to hypoperfusion
To test whether the functional integrity of white matter was altered in response to increased durations of hypoperfusion, extracellular CAPs were recorded in the transcallosal area of the corpus callosum. The post-stimulus latency of the CAP peak, as an index of conduction velocity, was recorded at different distances (from 1 mm to 2.5 mm from the stimulating electrode) in the corpus callosum (Fig.1). Peak latency increased with prolonged durations of hypoperfusion (Fig.1A-C) indicative of an impaired conduction velocity in myelinated tracts. There was a significant increase in the CAP peak latency after 6 weeks (p < 0.05, Fig.1B, E) and 12 weeks (p < 0.001; Fig.1C, F) of hypoperfusion. To determine if there was any severe functional loss of white matter fibres in response to hypoperfusion the maximal peak amplitude of the CAP was compared between groups after increasing the stimulus strength from 0.25 to 4 mA. There was no significant change in the peak amplitude of myelinated fibres (data not shown) at any time-point studied indicating a lack of substantial axonal loss in our model of hypoperfusion. 

Progressive loss of paranodal and internodal axon-glial integrity in response to hypoperfusion 
Our group has previously described alterations in axon-glial integrity in response to hypoperfusion (Reimer, 2011), associated with a disruption in the structural organisation of key proteins of the paranodal and internodal axonal domains (Fig.2A). To investigate whether the nodal-paranodal domains were altered in response to increasing durations of hypoperfusion, double-labelling of sections with antibodies against Caspr (paranodes) and Nav1.6 (Node of Ranvier) were performed. As a measure of paranodal integrity the distance between a pair of paranodes (Caspr+ clusters) from the same node (nodal gap length) was measured at 1 week, 6 weeks and 12 weeks (Fig.2B-E). Although no alterations were detected at early time-points (1 week Fig.2F; 6 weeks Fig.2G), a significant reduction in the nodal gap length was observed after 12 weeks of hypoperfusion (Fig.2H). To examine whether alterations in the nodal-paranodal integrity could be related with white matter function the correlation between peak latency and nodal gap length was tested. Notably there was a significant correlation between peak latency and nodal gap length in sham animals (Fig.2I; Spearman r = -0.38, p < 0.05) but no relation between peak latency and nodal gap length was determined in hypoperfused animals (Fig.2J; Spearman r = -0.05, p > 0.05) suggesting that paranodal integrity is important for proper axonal function under physiological conditions.

To explore paranodal axon-glial integrity, the nodal-paranodal ratio, which results from dividing the length of the sodium channel cluster of a given node by its nodal gap length, was calculated (Fig.3A). In normal conditions, this ratio is close to 1, since the different proteins of the axonal domains have a very distinctive and well-defined spatial distribution with limited over-lap between domains (Fig. 3B). Deviations in this ratio could be indicative of loss of axon-glial integrity (Fig.3B). Consistent with our paranodal integrity results, the nodal-paranodal ratio was unchanged at early time-points (Fig.3C,D) but was significantly shifted 12 weeks after surgery (Fig.3E), indicating a loss of axon-glial integrity with increasing durations of hypoperfusion. 

Internodal axon-glial integrity was further assessed using MAG immunohistochemistry in the corpus callosum. With increasing durations of hypoperfusion a progressive increase of myelin debris and vacuolation was determined (Fig.3G-I) which was absent in shams (Fig,3F). In line with paranodal data, no significant differences were found between groups at early time-points after surgery (1 week: 0.17 ± 0.39 sham vs 0.89 ± 0.60 hypoperfused p > 0.05; 6 weeks: 0.50 ± 0.67 sham vs 1.17 ± 1.03 hypoperfused p > 0.05) but there was a significant effect of hypoperfusion on axon-glial integrity 12 weeks after surgery (0.83 ± 0.72 sham vs 1.56 ± 0.88, p<0.05) further supporting the disruption of axon-glial integrity in response to hypoperfusion.

Gradual increase of microgliosis relates to impaired structural and functional integrity of white matter in response to hypoperfusion
A prominent feature of the model of cerebral hypoperfusion is a  robust increase in microglia number (Coltman, 2011; Holland, 2011; McQueen, 2014; Reimer, 2011). To determine if the inflammatory response was increased in response to different durations of hypoperfusion the number of microglial cells was counted in the corpus callosum of Iba-1 stained sections (Interaural 1.74 mm; Bregma 2.06 mm). The number of Iba-1+ cells gradually increased in response to prolonged durations of hypoperfusion (Fig.4A-C). As early as 1 week after hypoperfusion (Fig.4A), microglial numbers were increased compared to control. At 6 weeks and 12 weeks this increase in microglia was pronounced and significantly greater than that observed in controls (p < 0.05 Fig.4B-C). 

It was then determined whether the increase in Iba-1 positive cells, found in the corpus callosum post-hypoperfusion, were microglia in origin or driven by macrophage infiltration. The recently developed microglia specific marker TMEM119  ADDIN EN.CITE (Bennett et al., 2016) was co-localised with Iba-1 and quantified to delineate infiltrating macrophage cells from resident microglia. Representative images are shown of Iba-1 immunostaining in sham (Fig.4D) and hypoperfused (Fig 4H); TMEM119 immunostaining in sham (Fig.4E) and hypoperfused (Fig.4I)  and  then Iba-1 / TMEM119 co-localisation in sham (Fig. 4F,G) and hypoperfused (Fig.4J,K) white matter. All (100%) Iba-1+ cells in both sham (Fig.4D) and hypoperfused cohorts (Fig.4H) were also TMEM119+ (Fig.4 E and 4I) indicating that the cells in the corpus callosum  were microglia and the increase was not driven by macrophage infiltration. 

To investigate whether the increase in microglial cells was associated with the loss of paranodal and axon-glial integrity, the correlations between nodal gap length and number of microglial cells, and nodal/paranodal ratio and number of microglial cells were tested. Remarkably, there was an overall negative correlation between the length of the nodal gap and the microglial counts (Fig.4L; Spearman r = -0.55, p < 0.0001), indicating that higher levels of microglia correlate with reductions in the nodal gap length (i.e. loss of paranodal integrity). In addition, there was a positive correlation between axon-glial integrity and microglial number (Fig.4M; Spearman r = -0.37, p < 0.005). To determine whether the microgliosis could also be related to the progressive worsening of white matter function, the correlation between peak latency and the number of microglial cells was tested. Interestingly, there was an overall positive correlation between the number of microglial cells and the peak latency (Fig.4N; Spearman r = 0.37, p < 0.005), suggesting that higher levels of inflammation relate to greater deficits in the functional integrity of white matter over time.

Altogether, the results suggest that there might be a direct association between hypoperfusion-induced white matter microgliosis and disruption of paranodal and internodal integrities (Fig.5). Interestingly, it seems that areas devoid of activated microglia (Fig.5C, G) are associated with highly organised myelin fibres (Fig.5A, E) and well-preserved Caspr at paranodes (Fig.5B, F) whereas activated microglia in hypoperfusion (Fig.5K, O) are associated with disorganized myelinated tracts (Fig.5I, M) and a loss of  paranodal integrity (Fig.5J, N). Since the integrity of axonal domains is critical for efficient neuronal communication, this could ultimately impact on white matter function and cognition. 

Minocycline treatment reduces microgliosis and restores white matter functional integrity after hypoperfusion
To test whether microglia contribute to the functional impairment of white matter after hypoperfusion, we investigated the effects of minocycline. Treatment was initiated 1 day after sham or hypoperfusion surgery and lasted for 10 weeks. Notably, minocycline treatment effectively restored white matter functional integrity (Fig.6A). The peak latency of CAPs was significantly increased in hypoperfused vehicle treated mice compared to sham vehicle treated mice (p < 0.05). In contrast, minocycline-treated hypoperfused mice had similar peak latencies to the sham controls (p > 0.05) but  had significantly reduced peak latencies compared to control hypoperfused mice (p < 0.05).  Similar to the previous study, hypoperfusion significantly increased the number of microglia as compared to sham controls (p < 0.05, Fig.6B). However the number of microglia in minocycline-treated hypoperfused mice were not significantly different to that of controls (Fig.6B). We next determined  whether hypoperfusion influenced proliferation of microglia and if this was affected by minocycline. Iba-1 stained sections were double labelled with the proliferation marker Ki67 (see representative images Fig.6E). Overall, there was no significant difference in the % of co-localised Iba-1 immunostained cells with Ki67 (p=0.057) between the groups (sham, hypoperfused vehicle, hypoperfused minocycline treated). However, it was noted that there was evidence of microglial proliferation in hypoperfused mice which was absent from sham vehicle treated mice. Further the number of proliferating microglia was reduced in minocycline treated mice as compared to hypoperfused vehicle treated mice (Fig. 6D).





Expression of inflammatory genes are not altered  in response to hypoperfusion




Previous studies, including our own, indicated that disruption of white matter structure induced by chronic cerebral hypoperfusion (Shibata et al. 2004; Coltman et al. 2011; Holland et al. 2011; Reimer et al. 2011) is closely linked with a robust increase in microglia number. However to date it was unclear whether these structural changes in white matter are related to a functional impairment in white matter and second to this whether increased microglia contribute to these changes.  The current study demonstrates that cerebral hypoperfusion induces a progressive impairment of white matter function which is closely related to axon-glial disruption and increased numbers of resident microglia. Furthermore, minocycline, an agent that can inhibit microglia proliferation and exert anti-inflammatory properties, restores the functional and structural breakdown of white matter integrity caused by chronic cerebral hypoperfusion. 

The mouse model of cerebral hypoperfusion used in the current study has been well characterised by our group and others (Shibata, 2004; Coltman, 2011; Holland, 2011; McQueen, 2014; Reimer, 2011; Holland, 2015) and has proven informative in providing mechanistic insight to cerebral vascular disease in which cerebral hypoperfusion and white matter damage are central to the pathophysiology. The current study builds on our previous work which demonstrated the vulnerability of axon-glial domains of myelinated axons to mild cerebral hypoperfusion (Reimer, 2011) and now shows that these structural changes in white matter are associated with a pronounced functional impairment of white matter connectivity.  It is widely accepted that the integrity of the brain’s white matter is critical in regulating efficient neuronal communication and maintaining cognitive function. Rapid saltatory conduction relies on the highly organised molecular structure of myelinated fibres into distinctive domains comprising the node of Ranvier, the paranode, the juxtaparanode and the internode (Hartline and Colman, 2007). Amongst these domains, the paranode, that flanks the node of Ranvier in myelinated axons, is a key region to maintain white matter architecture. The paranodal septate-like junction, which constitutes the major site of attachment between the glial cell and the axon, acts as an electrical and biochemical barrier between axonal domains (Buttermore, 2013) and its integrity has been proven to be fundamental for proper axonal communication. For instance, studies using knockout mice deficient for proteins key in axon-glial connection at paranodal regions such as contactin, caspr and neurofascin155 show severe reductions in nerve conduction velocity even in the absence of gross myelin or axon pathology (Bhat, 2001; Boyle, 2001; Pillai, 2009). Moreover, alterations in the distribution of these proteins have also been shown to have a negative impact on axon-glial integrity and axonal function (Nie, 2006; Tanaka, 2009; Hayashi, 2013; Ritter, 2013) and mathematical models indicate that even subtle paranodal disruption can significantly influence conduction velocity (Babbs and Shi, 2013). Another protein essential for axon-glial interaction is MAG which is selectively localized at the periaxonal space of internodes (Quarles, 2007). Due to its specific location, far from the oligodendrocyte cell body, MAG has been shown to be more susceptible to hypoxia-like insults than other internodal proteins such as myelin basic protein or proteolipid protein (Aboul-Enein, 2003; Barker, 2013). To date, most of the white matter functional evidence has been generated from studies in peripheral nerves and only a few of these measure white matter function in the CNS (Teigler, 2009; Ritter, 2013; Murcia-Belmonte, 2015). Noteworthy, these CNS studies further support the idea that changes in axonal domains could influence axonal conduction velocity. Taken together, current literature suggests that alterations in the distribution and/or molecular architecture of these discrete domains could have a dramatic impact on axonal function. Hence, the subtle but significant alterations observed in the structural architecture of axonal domains in our mild hypoperfusion model could explain, at least in part, the deficits observed in conduction velocity. In support of this, nodal gap length measurement correlated with conduction velocity in normal healthy animals, but not in the hypoperfused ones, perhaps highlighting the importance of nodal gap integrity for proper action potential propagation.

In the present study as early as 1 week after hypoperfusion, microglia numbers increase in the corpus callosum (20% increase vs sham) and increase further after 6 and 12 weeks after hypoperfusion. Investigation was undertaken to determine whether  Iba-1 positive cells  were microglial in origin or driven by macrophage infiltration. To address this we used the antibody TMEM119 recently described by the Barres group as specific for microglia and not invading monocytes (Bennett et al, 2016). Our data convincingly shows 100% overlap between Iba-1 positive cells and TMEM119 positive cells in the white matter in this model of hypoperfusion.  Thus infiltrating monocytes do not appear to contribute to this pool of Iba-1 labelled cells in the corpus callosum. This increase in microglia could also be accounted for in part by local proliferation determined by an increase in Iba-1/Ki67 labelled cells after hypoperfusion. Noteworthy, the number of microglial cells was significantly associated with nodal gap length and axon-glial disruption in our study. Higher numbers of microglial cells correlated with decreased nodal gap length and increased paranodal axon-glial disruption, perhaps supporting the idea that the structural alterations observed in response to hypoperfusion could be secondary to an inflammatory response. 

To test whether there was a causal relation between increased microglia and impaired white matter function after cerebral hypoperfusion we investigated the effect of minocycline. This drug, can readily penetrate the blood brain barrier, and it  has been shown to improve  white matter structure (Jalal et al. 2015; Yrjänheikki, 1999; Yang, 2015a). The current study provided new information to show that minocycline has beneficial effects both restoring the functional impairment induced by hypoperfusion and reducing microglia number. This study extends previous reports that have focussed on the effects of minocycline on white matter structure. Studies using experimental autoimmune encephalomyelitis mouse models and samples from multiple sclerosis individuals report an association between local microglial activation and disruption of nodal-paranodal domains in areas of normal-appearing white matter. Treatment with minocycline, reduced microgliosis and nodal/paranodal disruption albeit no functional alterations were investigated (Howell, 2010). Minocycline has also been effectively used in models of hypoxia-ischemia insult (Cho, 2006; Jalal, 2015; Ma, 2015; Yang, 2015b), hyperoxia (Schmitz, 2014), demyelination (Skripuletz, 2010) and intracerebral haemorrhage (Power, 2003; Yan, 2015). In these studies, minocycline significantly reduced microgliosis and promoted neuroprotection as evidenced by the attenuation of white matter damage (Cho, 2006; Skripuletz, 2010; Schmitz, 2014; Jalal, 2015; Ma, 2015; Yang, 2015b) but a direct functional on white matter  was not investigated. Our new data demonstrate minocycline has beneficial effects on white matter function. A number of mechanisms for the mode of action of minocycline have been proposed in addition to microglia inhibition and anti-inflammatory properties including effects on other cells such as oligodendrocytes (Moller et al. 2016). In the present study, the mechanism by which minocycline exerts protective effects on white matter function remains unclear. There was evidence that microglial proliferation was reduced with minocycline treatment. We also measured expression of a range of inflammatory marker genes (e.g. Nos2, Arg1, Trem1, Trem2, Il10, H2-Aa, Il4ra) in isolated white matter by qPCR. However we did not detect changes in response to hypoperfusion alone therefore any effects of minocycline on the inflammatory profile were not possible to determine. This was perhaps not surprising given the subtle nature of the hypoperfusion insult. However, to increase the sensitivity of detection future studies should aim to assess gene alterations in isolated microglia from the white matter. It is also important that microglia phenotype is defined in different models and in disease since this may influence the response to drug treatment and exert different effects on disease progression. Whilst the current study would suggest that reducing microglia number in a model of cerebral hypoperfusion has beneficial effects, in other studies of severe hypoperfusion occurring after stroke, transplanted human microglial cells have been shown to exert  neuroprotective effects and improve  functional recovery (Narantuya et al. 2010) whereas ablating microglia worsens injury (Lalancette-Hébert et al. 2007;  Szalay et al. 2016).  At the present time some caution needs to be exerted in translating these preclinical findings to drug studies in patient cohorts.  It is important that microglial phenotype and broader neuroinflammatory environment at the time of drug administration is further investigated  since the response may differ. 





Acknowledgements (​http:​/​​/​www.jneurosci.org​/​site​/​misc​/​ifa_organization.xhtml" \l "Acknowledgements​):






ADDIN Mendeley Bibliography CSL_BIBLIOGRAPHY Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. 2003. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol  62:25–33. 
Babbs CF, Shi R. 2013. Subtle paranodal injury slows impulse conduction in a mathematical model of myelinated axons. PLoS One  8:e67767. 
Barker R, Wellington D, Esiri MM, Love S. 2013. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 33:1050–7. 
Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S. 2014. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​24618270​) Brain. 137(Pt 5):1524-32. 
Bastin, M.E., Clayden, J.D., Pattie, A., Gerrish, I.F., Wardlaw, J.M., Deary, I.J. 2009. Diffusion tensor and magnetization transfer MRI measurements of periventricular  white matter hyperintensities in old age. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​17624630?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=3​) Neurobiol. Aging  30(1):125-36.
Benjamin P, Zeestraten EA, Lambert C, Chis Ster IC, Williams OA, Lawrence AJ, Patel B, Mackinnon AD, Barrick TR, Markus HS. 2015. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J Cereb Blood Flow Metab.. 3;1–8

Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, Weissman IL, Chang EF, Li G, Grant GA, Hayden Gephart MG, Barres BA (2016) New tools for studying microglia in the mouse and human CNS. Proceedings of the National Academy of Sciences of the United States of America 113:E1738-1746.

Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, Li J, Einheber S, Chesler M, Rosenbluth J, Salzer JL, Bellen HJ. 2001. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron  30:369–83. 
Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. 2001. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron  30:385–97. 
Bucur, B., Madden, D.J., Spaniol, J., Provenzale, J.M., Cabeza, R., White, L.E., Huettel, S.A. 2008. Age-related slowing of memory retrieval: contributions of perceptual speed and cerebral white matter integrity. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​17383774?ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum​) Neurobiol. Aging 1070-9.
Buttermore ED, Thaxton CL, Bhat MA. 2013. Organization and maintenance of molecular domains in myelinated axons. J Neurosci Res  91:603–22. 
Chen A, Akinyemi RO, Hase Y, Firbank MJ, Ndung'u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O'Brien JT, Horsburgh K, Ihara M, Kalaria RN. 2016. Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​26667280​) Brain 139(Pt 1):242-58. 
Cho K-O, La HO, Cho Y-J, Sung K-W, Kim SY. 2006. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res 83:285–91. 
Coltman R, Spain A, Tsenkina Y, Fowler JH, Smith J, Scullion G, Allerhand M, Scott F, Kalaria RN, Ihara M, Daumas S, Deary IJ, Wood E, McCulloch J, Horsburgh K. 2011. Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 32:2324.e7–12. 
Crawford DK, Mangiardi M, Tiwari-Woodruff SK. 2009. Assaying the functional effects of demyelination and remyelination: revisiting field potential recordings. J Neurosci Methods  182:25–33. 
Duan W, Gui L, Zhou Z, Liu Y, Tian H, Chen J-F, Zheng J. 2009. Adenosine A2A receptor deficiency exacerbates white matter lesions and cognitive deficits induced by chronic cerebral hypoperfusion in mice. J Neurol Sci  285:39–45. 
Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, Kalaria RN, Forster G, Esteves F, Wharton SB, Shaw PJ, O’Brien JT, Ince PG. 2006. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke  37:1391–8. 
Fu Y, Sun W, Shi Y, Shi R, Cheng J-X. 2009. Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction. PLoS One  4:e6705.
Hartline DK, Colman DR. 2007. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol  17:R29–35. 
Hayashi A, Kaneko N, Tomihira C, Baba H. 2013. Sulfatide decrease in myelin influences formation of the paranodal axo-glial junction and conduction velocity in the sciatic nerve. Glia 61:466–74. 
Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CRG, Greenberg SM. 2008. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke  39:1127–33. 
Holland PR, Bastin ME, Jansen MA, Merrifield GD, Coltman RB, Scott F, Nowers H, Khallout K, Marshall I, Wardlaw JM, Deary IJ, McCulloch J, Horsburgh K. 2011. MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging  32:2325.e1–6. 
Holland PR, Searcy JL, Salvadores N, Scullion G, Chen G, Lawson G, Scott F, Bastin ME, Ihara M, Kalaria R, Wood ER, Smith C, Wardlaw JM, Horsburgh K. 2015. Gliovascular disruption and cognitive deficits in a mouse model with features of small vessel disease. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​25669904​) J Cereb Blood Flow Metab.  35(6):1005-14 
Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. 2010. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 69:1017–33. 
Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, Englund E, O'Brien JT, Ince PG, Kalaria RN. 2010. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​20091409​) Acta Neuropathol 119(5):579-89. 
Jalal FY, Yang Y, Thompson JF, Roitbak T, Rosenberg GA. 2015. Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. J Cereb Blood Flow Metab  35:1145–53. 
Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. (​https:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​17344397​)  J Neurosci. 2007 27(10):2596-605.
Ma J, Zhang J, Hou WW, Wu XH, Liao RJ, Chen Y, Wang Z, Zhang XN, Zhang LS, Zhou YD, Chen Z, Hu WW. 2015. Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion. Sci Rep 5:12079. 
McQueen J, Reimer MM, Holland PR, Horsburgh K. 2014. Restoration of oligodendrocyte pools in a mouse model of chronic cerebral hypoperfusion  Plos One 9(2):e87227. 
Möller T, Bard F, Bhattacharya A, Biber K, Campbell B, Dale E, Eder C, Gan L, Garden GA, Hughes ZA, Pearse DD, Staal RG, Sayed FA, Wes PD, Boddeke HW. 2016. Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor. (​https:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​27246804​)   Glia. 64(10):1788-94. 
Murcia-Belmonte V, Esteban PF, Martínez-Hernández J, Gruart A, Luján R, Delgado-García JM, de Castro F. 2016. Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness. Brain Struct Funct 221(3):1365-85
Narantuya D, Nagai A, Sheikh AM, Masuda J, Kobayashi S, Yamaguchi S, Kim SU. 2010 Human microglia transplanted in rat focal ischemia brain induce neuroprotection and behavioral improvement. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​20668522​)  PLoS One. 5(7):e11746. doi: 10.1371/journal.pone.0011746.
Nie D-Y, Ma Q-H, Law JWS, Chia C-P, Dhingra NK, Shimoda Y, Yang W-L, Gong N, Chen Q-W, Xu G, Hu Q-D, Chow PKH, Ng Y-K, Ling E-A, Watanabe K, Xu T-L, Habib AA, Schachner M, Xiao Z-C. 2006. Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biol 2:151–64. 
O’Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM, Williams SCR, Markus HS. 2002. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 59:321–6. 
Pillai AM, Thaxton C, Pribisko AL, Cheng J-G, Dupree JL, Bhat MA. 2009. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains. J Neurosci Res 87:1773–93. 
Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, Yong VW, Peeling J. 2003. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol  53:731–742. 
Prins ND and Scheltens P. 2015. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol 11:157–65.
 Quarles RH. 2007. Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem 100:1431–48. 
Reimer MM, McQueen J, Searcy L, Scullion G, Zonta B, Desmazieres A, Holland PR, Smith J, Gliddon C, Wood ER, Herzyk P, Brophy PJ, McCulloch J, Horsburgh K.  2011. Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J Neurosci 31:18185–94. 
Ritter J, Schmitz T, Chew L-J, Bührer C, Möbius W, Zonouzi M, Gallo V. 2013. Neonatal hyperoxia exposure disrupts axon-oligodendrocyte integrity in the subcortical white matter. J Neurosci 33:8990–9002. 
Schmitz T, Krabbe G, Weikert G, Scheuer T, Matheus F, Wang Y, Mueller S, Kettenmann H, Matyash V, Bührer C, Endesfelder S. 2014. Minocycline protects the immature white matter against hyperoxia. Exp Neurol  254:153–65. 
Shibata M, Ohtani R, Ihara M, Tomimoto H. 2004. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35:2598–603. 
Simpson JE, Ince PG, Higham CE, Gelsthorpe CH, Fernando MS, Matthews F, Forster G, O'Brien JT, Barber R, Kalaria RN, Brayne C, Shaw PJ, Stoeber K, Williams GH, Lewis CE, Wharton SB; MRC Cognitive Function and Ageing Neuropathology Study Group 2007. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​17990995​)  Neuropathol Appl Neurobiol. 33(6):670-83.
Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, Stangel M. 2010. Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res 35:1422–33. 
Sloane JA, Hollander W, Moss MB, Rosene DL, Abraham CR. 1999. Increased microglial activation and protein nitration in white matter of the aging monkey. (​http:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​10604432​) Neurobiol Aging. 20(4):395-405.
Szalay G, Martinecz B, Lénárt N, Környei Z, Orsolits B, Judák L, Császár E, Fekete R, West BL, Katona G, Rózsa B, Dénes Á.  2016. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. (​https:​/​​/​www.ncbi.nlm.nih.gov​/​pubmed​/​27139776​)  Nat Commun. 7:11499.
Tanaka H, Ma J, Tanaka KF, Takao K, Komada M, Tanda K, Suzuki A, Ishibashi T, Baba H, Isa T, Shigemoto R, Ono K, Miyakawa T, Ikenaka K. 2009. Mice with altered myelin proteolipid protein gene expression display cognitive deficits accompanied by abnormal neuron-glia interactions and decreased conduction velocities. J Neurosci 29:8363–71. 
Teigler A, Komljenovic D, Draguhn A, Gorgas K, Just WW. 2009. Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum. Hum Mol Genet 18:1897–908. 
Yan P, Zhu A, Liao F, Xiao Q, Kraft AW, Gonzales E, Perez R, Greenberg SM, Holtzman DM, Lee J-M. 2015. Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy. Stroke 46:1633–40. 
Yang F, Zhou L, Wang D, Wang Z, Huang Q-Y. 2015a. Minocycline ameliorates hypoxia-induced blood-brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway. Neuroscience  304:250–9. 
Yang Y, Salayandia VM, Thompson JF, Yang LY, Estrada EY, Yang Y. 2015b. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery. J Neuroinflammation  12:26. 




Figure 1. Progressive impairment of the functional integrity of myelinated axons in response to increased durations of hypoperfusion
Latency to CAP peak was progressively increased with increasing durations of hypoperfusion (A-C) indicative of impaired conduction velocity of myelinated axons. There were no significant differences following hypoperfusion at 1 week (A, D) but CAP latency was significantly increased after 6 weeks (B, E) and further at 12 weeks (C, F). Data are mean ± SEM, n=9-12/group. * p < 0.05, ***p < 0.001

Figure 2. Decreased nodal gap length after hypoperfusion
Schematic representation of the axonal domains (A). The nodal gap length, i.e the distance between two paranodes of the same node, was determined using the paranodal protein Caspr (B). Forty Caspr pairs were analysed per animal (20 per hemisphere) and these 360-480 nodal gap lengths are plotted as cumulative frequency distribution (F-H). Significant reduction in the nodal gap length was observed after 12 weeks of hypoperfusion (E, H) but not at earlier time-points (C, F, D, G). There was an overall negative correlation between nodal gap length and peak latency in sham (I) but not in hypoperfused (J) mice (Spearman r = -0.38, p < 0.05; Spearman r = -0.05, p > 0.05, respectively). n=9-12/group. **p < 0.01. Scale bar 1 μm.

Figure 3. Disrupted axon-glial integrity after hypoperfusion
Schematic to indicate the nodal-paranodal ratio, which is close to 1 in intact nodes (A), and results from dividing the nodal length of a given node by its nodal gap length which is indicative of axon-glial integrity. (B) Representative images to highlight the normal spatial relationship between the node (Nav1.6) and paranodes (Caspr) in a sham and the disruption with hypoperfusion. Scale bar 1 μm. No differences in the nodal-paranodal ratio were observed after 1 (C) and 6 (D) weeks of hypoperfusion but it was significantly shifted 12 weeks after hypoperfusion (E) suggesting a loss of nodal-paranodal integrity at this time point. Ratio data is plotted as relative frequency. n=9-12/group. *p <0.05. (F-I) Representative images of myelin-associated glycoprotein (MAG) staining showing normal tissue (F) and progressive loss of axon-glia integrity in the corpus callosum with increasing durations of hypoperfusion (G-I). Myelin debris (arrow) and vacuolation (asterisk) were gradually increased after hypoperfusion compared to sham operated mice. Scale bar 25 μm.

Figure 4. Microgliosis is increased in response to hypoperfusion and is associated with structural and functional alterations
Iba-1 labelled microglia show a progressive increase in the corpus callosum of hypoperfused mice (A-C). The number of microglial cells increased after hypoperfusion and were significantly greater  at 6 (B) and 12 weeks (C) compared to sham (*p <  0.05). Representative images of sham (D-G) and hypoperfusion (H-K) at 12 weeks post-surgery are shown to illustrate  Iba-1 immunostaining in sham (D) and hypoperfused (H); TMEM119 immunostaining in sham (E) and hypoperfused (I)  and  then Iba-1 / TMEM119 co-localisation in sham (F,G) and hypoperfused (J,K) white matter. All Iba-1+ cells in both sham  and hypoperfused cohorts were also TMEM119+  indicating that the cells in the corpus callosum  were resident microglia.  Scale bars; D-F and H-J are 50µm, G and K 10µm. The number of microglial cells significantly correlated with nodal gap length (L; Spearman r = 0.55, p < 0.0001), axon-glial integrity (M; Spearman r = 0.37, p < 0.005) and CAP peak latency (N; Spearman r = 0.37, p < 0.005). Data are mean ± SEM, n=9-12/group. * p <  0.05. 

Figure 5. Gradual increase in microglial cells at the corpus callosum is associated with axon-glial integrity loss.
Representative images (A-P) of a triple staining labelling for MAG (red), Caspr (green) and Iba-1 (white) at low (40x) and high magnification (100x). Areas devoid of activated microglia (C, G) are associated with highly organised myelin fibres (A, E) and well-preserved caspr pairs (B, F) and gradual increase in activated microglia (K, O) is associated with disorganized fibre structure (I, M) and loss of paranodal integrity (J, N). Scale bar 40x 25 μm; scale bar 100x 10 μm. 

Figure 6. Minocycline treatment reduces microgliosis and improves white matter functional integrity
The latency to CAP of myelinated axons (A) was significantly increased after hypoperfusion and treatment with minocycline restored peak latency values to those of sham animals. Hypoperfusion significantly increased the number of microglia as compared to sham controls (B). The number of microglia in minocycline-treated hypoperfused mice were not significantly different to that of controls (B) indicating that minocycline treatment dampened the hypoperfusion-induced microgliosis. The number of microglial cells significantly correlated with peak latency (C; Pearson r = 0.57, p < 0.002) further highlighting the close association between inflammation and white matter functional integrity.  There was no overall difference in the % double labelled Iba1/Ki67 cells (proliferating microglia) across the groups. Notably proliferating microglia were absent in shams  and present in  hypoperfused groups with fewer proliferating cells in the minocycline treated compared to vehicle treated  group (D). Representative images of Iba-1 (brown) and Ki67 (black) immunolabelling; the inserts show microglia and highlights the lack of co-localisation in sham mice and presence in hypoperfused mice (E). Scale bar 10 μm Data are mean ± SEM, n=9-10/group. * p < 0.05.

Figure 7: The effect of minocycline on the inflammatory profile of the corpus callosum in response to prolonged hypoperfusion.  RT-qPCR analysis of gene expression in the corpus callosum following 12 weeks sham, or hypoperfusion or hypoperfusion and minocycline treatment. Cycle threshold (Ct) values of target genes were normalised to Gapdh and expression fold changes relative to sham group determined using 2^∆∆Ct method. Data show mean ± SEM, n = 8-10 per group. There were no statistical differences in gene expression between the groups.
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